Credit: Gorodenkoff Productions OU/Adobe Stock

Obesity shots like Wegovy are already a cultural phenomenon. Now it’s looking like pill forms of the drugs from Eli Lilly & Co. and Novo Nordisk A/S are just as good at helping people lose weight, setting the stage for even more explosive growth in the years ahead.

Novo and Lilly’s experimental obesity pills helped people lose about 15% of body weight, similar to weight-loss shots on the market already, according to findings presented at the American Diabetes Association’s conference over the weekend. Meanwhile, Pfizer Inc. said it will discontinue one of its weight loss pills under development as safety concerns arose.

Complete your profile to continue reading and get FREE access to, part of your ALM digital membership.

Your access to unlimited content isn’t changing.
Once you are an ALM digital member, you’ll receive:

  • Critical information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
  • Exclusive discounts on ALM, BenefitsPRO magazine and events.
  • Access to other award-winning ALM websites including and

Already have an account?


© 2023 ALM Global, LLC, All Rights Reserved. Request academic re-use from All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.

BenefitsPRO Broker Expo 2024Event

The premier educational and networking event for employee benefits brokers and agents.

Get More Information


Join BenefitsPRO

Don’t miss crucial news and insights you need to navigate the shifting employee benefits industry. Join now!

  • Unlimited access to - your roadmap to thriving in a disrupted environment
  • Access to other award-winning ALM websites including and
  • Exclusive discounts on and ALM events.

Already have an account? Sign In Now
Join BenefitsPRO

Copyright © 2023 ALM Global, LLC. All Rights Reserved.